Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

More On IBT.V



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


IBEX Technologies, Inc. (IBT.V)

0.06 Down 0.01(7.69%) 10:59AM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
IBEX Technologies, Inc.
5485 Pare Street
Suite 100
Montreal, QC H4P 1P7
Canada - Map
Phone: 514-344-4004
Fax: 514-344-8827

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

IBEX Technologies Inc., a biopharmaceutical company, engages in the production and sale of proprietary enzymes for use as reagents in hemostasis monitoring devices. The company also provides arthritis diagnostic kits, including Collagen Type II Cleavage Assay that measures real-time collagen type II degradation; Collagen Type I and II Cleavage Assay, which measures the amount of real-time collagen of types I and II degradation; CPII Assay-Cartilage that monitors changes in the rate of synthesis of cartilage components of type II collagen indicative of osteoarthritis and rheumatoid arthritis; and Aggrecan Chondroitin Sulfate 846 Epitope Assay, which monitors changes in the rate of synthesis of cartilage components of aggrecan indicating osteoarthritis and rheumatoid arthritis. IBEX offers its arthritis diagnostic kits primarily for the pharmaceutical research. In addition, the company provides cartilage biomarker antibodies comprising Ab1320 Aggrecan NITEGE rabbit, Col M, Type IX Collagen, and C1-2C. Further, it offers heparinase II and heparinase III research reagents; chondroitinase AC that acts as a research reagent, and involved in degradation of hyaluronic acid; and chondroitinase B, a research reagent. Additionally, the company provides sample testing services. It sells its products primarily in Canada, the United States, and Europe. The company is based in Montreal, Canada.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on IBEX Technologies, Inc.

Key Executives 
Mr. Paul Baehr , 71
Chairman, Chief Exec. Officer and Pres
Mr. Richard Collin CPA-CA,
Director of Fin.
Dr. Thomas O. Hecht Ph.D., M.D., 63
Independent Director, Chairman of Compensation Committee, Member of Audit Committee, Member of Corp. Governance Committee and Pres of Haemosan Inc
Mr. Claire Bergeron ,
VP of Admin.
Mr. Chee-Wui Chu ,
VP of Research
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.